Actinomycin D and Telmisartan Combination Targets Lung Cancer Stem Cells Through the Wnt/Beta Catenin Pathway

The failure of lung cancer treatments has been attributed mostly to the development of drug resistance, however the underlying cellular and molecular mechanisms are poorly understood. Cancer initiating stem cells (CSCs), present in tumors in a small percentage, play critical roles in the development...

Descripción completa

Detalles Bibliográficos
Autores principales: Green, Ryan, Howell, Mark, Khalil, Roukiah, Nair, Rajesh, Yan, Jiyu, Foran, Elspeth, Katiri, Sandhyabanu, Banerjee, Jit, Singh, Mandip, Bharadwaj, Srinivas, Mohapatra, Shyam S., Mohapatra, Subhra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6890794/
https://www.ncbi.nlm.nih.gov/pubmed/31796785
http://dx.doi.org/10.1038/s41598-019-54266-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6890794/
https://www.ncbi.nlm.nih.gov/pubmed/31796785
http://dx.doi.org/10.1038/s41598-019-54266-z

Ejemplares similares